Sign In

Myla Lai-Goldman

Co-Founder and Chair at GeneCentric Therapeutics, Inc.

Dr. Myla Lai-Goldman is a prominent figure in the biotechnology and healthcare sectors, serving as the Co-Founder and Chair of GeneCentric Therapeutics, Inc., a company she co-founded in 2011 to develop innovative cancer diagnostics based on RNA technology. Under her leadership, GeneCentric has created several proprietary assays for tumor subtyping, significantly advancing precision medicine in oncology.12

Professional Background

Dr. Lai-Goldman has over 25 years of experience in the development and commercialization of molecular diagnostic assays. Prior to her role at GeneCentric, she spent 18 years at Laboratory Corporation of America (LabCorp), where she held various executive positions including Executive Vice President, Chief Medical Officer, and Chief Scientific Officer. During her tenure at LabCorp, she was responsible for overseeing strategic operations across major genomic laboratories and led the introduction of more than 400 clinical assays.125

After leaving LabCorp in 2008, she became a Venture Partner at Hatteras Venture Partners and founded Personalized Science, LLC, a consulting firm focused on innovative diagnostics. In addition to her roles at GeneCentric, Dr. Lai-Goldman serves on the boards of several companies including West Pharmaceutical Services and Qvella Corporation.25

Education

Dr. Lai-Goldman earned her Bachelor of Arts in Biology from the University of Pennsylvania and her Doctor of Medicine (MD) from the Columbia University College of Physicians and Surgeons. She is board-certified in both anatomic and clinical pathology, reflecting her extensive training and expertise in the medical field.14

Contributions to Medicine

Dr. Lai-Goldman's work has been pivotal in advancing cancer diagnostics through innovative technologies that leverage RNA-based informatics. Her leadership at GeneCentric has positioned the company at the forefront of developing diagnostic tests that can guide personalized cancer treatments.35

Highlights

Apr 24 · businesswire.com
Mercy BioAnalytics Appoints Diagnostics Industry Trailblazer Dr ...
Mercy BioAnalytics Appoints Diagnostics Industry Trailblazer Dr ...

Related Questions

What are some of the key achievements of Myla Lai-Goldman at GeneCentric Therapeutics?
How did Myla Lai-Goldman's role at LabCorp prepare her for her current position?
What is the Cancer Subtype Platform developed by GeneCentric Therapeutics?
How has Myla Lai-Goldman contributed to the development of molecular diagnostic assays?
What are the main responsibilities of Myla Lai-Goldman as Executive Chairperson at GeneCentric Therapeutics?
Myla Lai-Goldman
Myla Lai-Goldman, photo 1
Myla Lai-Goldman, photo 2
Add to my network

Location

South Burlington, Vermont, United States